untillabs
untillabs (handle: @untillabs) publishes concise technical updates and social posts focused on reversible cryopreservation and organ-scale rewarming milestones. Coverage centers on technology signals rather than commercial timelines or tradable recommendations.
Past bets that played out
Highlights a technology milestone: Until Labs reported passing the ice-formation “danger zone” in under a minute using only a few kW, demonstrated at pig-kidney scale and described as having new “human organ-scale rewarming data.” The posts are a proof-of-concept signal referencing a likely private company and provide no commercialization timeline, regulatory pathway, or investable signals.
Social post highlighting Until Labs’ reversible cryopreservation/rewarming progress: passing the ice-formation “danger zone” in under a minute using only a few kW, demonstrated on pig-kidney scale with new “human organ-scale rewarming data.” This is a technology milestone signal, but it references a (likely) private company and provides no commercialization timeline.
Social post highlighting Until Labs’ reversible cryopreservation/rewarming progress: passing the ice-formation “danger zone” in under a minute using only a few kW, demonstrated on pig-kidney scale with new “human organ-scale rewarming data.” This is a technology milestone signal, but it references a (likely) private company and provides no commercialization timeline.
Social post highlighting Until Labs’ reversible cryopreservation/rewarming progress: passing the ice-formation “danger zone” in under a minute using only a few kW, demonstrated on pig-kidney scale with new “human organ-scale rewarming data.” This is a technology milestone signal, but it references a (likely) private company and provides no commercialization timeline.
What this channel is watching now
Recent mentions concentrate on cryopreservation and life-science instrumentation: CYRX, AZTA, Thermo Fisher Scientific (TMO), Danaher (DHR), and TMDX. The commentary emphasizes technical progress on reversible cryopreservation and rewarming rather than earnings, valuation, or market timing.
Latest videos and market context
No recent videos. Recent source content consists of social posts and blog updates describing reversible cryopreservation progress and event posts.
Until @untillabs 35m We've started hosting monthly community dinners at Until!🥳 We’re hoping to create a community of...
Social/community update from Until Labs about hosting monthly community dinners; no market-moving info, financial data, or tradable implications.
Until @untillabs 16m At Until Labs, interdisciplinary isn’t just a hype word. Here you’ll find our CNC machine, molec...
A short promo post from Until Labs describing in-house interdisciplinary R&D capabilities (CNC machining, molecular biology lab, organ perfusion station, power-electronics dry lab) with a link to learn more. No explicit public-company catalysts, product announcements, contracts, funding, timelines, or measurable claims.
Until @untillabs 15m Need a part? We’ll make it ourselves. 🛠️ Come build with us, we’re hiring engineers, see our ope...
A short hiring/branding post from Until Labs (appears private) about making parts in-house and hiring engineers. No financials, catalysts, product details, or public-company references.
Until @untillabs Jun 9 Did you catch our latest blog post on our rewarming machine? 👀 With our magnet, a kidney can s...
Until Labs (@untillabs) promotes a blog post about a “rewarming machine” using a magnet to rapidly rewarm a kidney through the ice-formation “danger zone” in under a minute, drawing only a few kilowatts (usable from standard hospital outlets). This is product/technology marketing; no public-company financials, contracts, trials, regulatory status, or adoption signals are provided.
Proof-backed call history
Outputs are primarily social posts and blog updates. Recent items include a film screening/Q&A post, multiple posts about reversible cryopreservation and proprietary rewarming processes (including pig-kidney and human organ–scale rewarming data claims), and one link-only post with no analyzable content.
A short promo post from Until Labs describing in-house interdisciplinary R&D capabilities (CNC machining, molecular biology lab, organ perfusion station, power-electronics dry lab) with a link to learn more. No explicit public-company catalysts, product announcements, contracts, funding, timelines, or measurable claims.
A short hiring/branding post from Until Labs (appears private) about making parts in-house and hiring engineers. No financials, catalysts, product details, or public-company references.
Social post highlighting Until Labs’ reversible cryopreservation/rewarming progress: passing the ice-formation “danger zone” in under a minute using only a few kW, demonstrated on pig-kidney scale with new “human organ-scale rewarming data.” This is a technology milestone signal, but it references a (likely) private company and provides no commercialization timeline.
Social post highlighting Until Labs’ reversible cryopreservation/rewarming progress: passing the ice-formation “danger zone” in under a minute using only a few kW, demonstrated on pig-kidney scale with new “human organ-scale rewarming data.” This is a technology milestone signal, but it references a (likely) private company and provides no commercialization timeline.
Social post highlighting Until Labs’ reversible cryopreservation/rewarming progress: passing the ice-formation “danger zone” in under a minute using only a few kW, demonstrated on pig-kidney scale with new “human organ-scale rewarming data.” This is a technology milestone signal, but it references a (likely) private company and provides no commercialization timeline.
Social post highlighting Until Labs’ reversible cryopreservation/rewarming progress: passing the ice-formation “danger zone” in under a minute using only a few kW, demonstrated on pig-kidney scale with new “human organ-scale rewarming data.” This is a technology milestone signal, but it references a (likely) private company and provides no commercialization timeline.
Social post highlighting Until Labs’ reversible cryopreservation/rewarming progress: passing the ice-formation “danger zone” in under a minute using only a few kW, demonstrated on pig-kidney scale with new “human organ-scale rewarming data.” This is a technology milestone signal, but it references a (likely) private company and provides no commercialization timeline.
About this channel
untillabs posts short-form updates from the Until Labs project, focusing on technical milestones in reversible cryopreservation and rewarming. Posts report experimental progress (e.g., passing the ice-formation danger zone quickly with low power at organ-relevant scale) but do not disclose company names, study protocols, partnerships, regulatory pathways, or commercialization timelines.
@untillabs
Most recognized assets
Unlock the full track record
Follow @untillabs for brief technical updates on cryopreservation milestones. These posts indicate technological progress but are not actionable investment recommendations.